Synthetic Biologics, Inc. (19) | Uncategorized (5)
Recent Contracts
-
Description of Securities of Synthetic Biologics, Inc
(Filed With SEC on March 16, 2022)
-
Technology Transfer Agreement between Bellvitge Biomedical Research Institute and VCN Biosciences S.L. dated August 31, 2010
(Filed With SEC on March 16, 2022)
-
DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
(Filed With SEC on March 4, 2021)
-
Description of Securities
(Filed With SEC on February 20, 2020)
-
Clinical Trial Agreement between Washington University School of Medicine in St. Louis and Synthetic Biologics, Inc. dated August 7, 2019
(Filed With SEC on August 8, 2019)